Identifying the molecular programs underlying human organ development and how they differ from 15 those in model species will advance our understanding of human health and disease. 16 Developmental gene expression profiles provide a window into the genes underlying organ 17 development as well as a direct means to compare them across species. We use a transcriptomic 18 resource for mammalian organ development to characterize the temporal profiles of human genes 19 associated with distinct disease classes and to determine, for each human gene, the similarity of its 20 spatiotemporal expression with its orthologs in rhesus macaque, mouse, rat and rabbit. We find 21 that half of human genes differ from their mouse orthologs in their temporal trajectories. These 22 include more than 200 disease genes associated with brain, heart and liver disease, for which mouse 23 models should undergo extra scrutiny. We provide a new resource that evaluates for every human 24 gene its suitability to be modeled in different mammalian species. 25 26 27 28 42 rhesus macaques) are routinely used as models of both normal human development and human 43 disease because it is generally assumed that the genes and regulatory networks underlying 44 development are largely conserved across these species. While this is generally true, there are also 45 critical differences between species during development, which underlie the large diversity of 46 3 mammalian organ phenotypes [1-6,8]. Identifying the commonalities and differences between the 47 genetic programs underlying organ development in different mammalian species is therefore 48 paramount for assessing the translatability of knowledge obtained from mammalian models to 49 understand human health and disease. Critically, gene expression profiles can be directly compared 50 between species, especially when they are derived from matching cells/organs and developmental 51 stages. Gene expression therefore offers a direct means to evaluate similarities and differences 52 between species in organ developmental programs. While the relationship between gene 53 expression and phenotypes is not linear, identifying when and where gene expression differs 54 between humans and other species will help identify the conditions (i.e., developmental stages, 55 organs, genes) under which model species may not be well suited to model human development 56 and disease. 57 58
Introduction 29
The genetic programs underlying human organ development are only partially understood, yet they 30 hold the key to understanding organ morphology, physiology and disease [1] [2] [3] [4] [5] [6] . Gene expression is 31 a molecular readout of developmental processes and therefore provides a window into the genes 32 and regulatory networks underlying organ development [7, 8] . By densely profiling gene expression 33 throughout organ development, we get one step closer to identifying the genes and molecular 34 processes that underlie organ differentiation, maturation and physiology [9] [10] [11] [12] [13] . We also advance 35 our understanding of what happens when these processes are disturbed and lead to disease. 36 Spatiotemporal gene expression profiles provide a wealth of information on human disease genes, 37 which can be leveraged to gain new insights into the etiology and symptomatology of diseases 38 [8, [14] [15] [16] . 39 40 Much of the progress made in unraveling the genetic programs responsible for human organ 41 development has come from research in model organisms. Mice and other mammals (e.g., rats and As expected, there is a clear match between the disease enrichments of each module and its organ 85 developmental profile ( Figure 1B) . For example, module M3 comprises 2,420 genes mainly 86 expressed in the liver and it is associated with a number of liver-related diseases (e.g., fatty liver). 87 Module M20 (822 genes) comprises genes mainly expressed in the heart and is associated with a 88 number of cardiomyopathies. Consistent with previous work [13] , we observe that modules 89 associated with higher expression early in development have a significantly higher fraction of TFs 90 than modules associated with higher expression late in development (Pearson's ρ: -0.71, P-value = 91 5 x 10 -6 ; Figure S1B ), a result that is consistent with TFs directing most of organogenesis. The 92 modules identified also provide a wealth of information on poorly characterized genes, that through 93 "guilt-by-association" can be assigned putative functions (Table S2 ). We identified a strong positive 94 correlation between the fraction of protein-coding genes in a module that are among the least 95 studied in the human genome [20] and the module's fraction of dynamic lncRNAs (ρ: +0.77, P-value 96 = 2 x 10 -7 ). Modules rich in dynamic lncRNAs and poorly studied protein-coding genes are frequently 97 associated with high expression in the gonads ( Figure 1B ) but are also found in association with high 98 expression in each of the other organs (e.g., module M9 for brain and module M11 for cerebellum). 99 
100
The breadth of developmental expression (i.e., the organ-and time-specificity of a gene) informs on 101 gene function, because it is expected to correlate with the spatiotemporal manifestation of 102 phenotypes. TFs, RBPs and members of the seven major signaling pathways all play key roles during 103 development but have distinct spatiotemporal profiles ( Figure S2 ; time-and organ-specificity are 104 strongly correlated [13] ). Consistent with previous observations [18] , RBPs are generally 105 ubiquitously expressed, with only 6% (100) showing time-and/or organ-specificity ( Figure S3 ). 106 Among these are the developmental regulators LIN28A and LIN28B, which are expressed at the 107 earliest stages across somatic organs; the heart-specific splicing factor RMB20, which has been 108 associated with cardiomyopathy; gonad-specific RBPs predicted to bind to piRNAs; and several 109 members of the ELAV family of neuronal regulators. Signaling genes also tend to be ubiquitously 110 expressed ( Figure S2 ), but they include a higher fraction (19-20%) of time-and/or organ-specific 111 genes than RBPs. As expected, the greatest variation in the breadth of spatiotemporal expression is 112 5 found among classes of TFs ( Figure S2 ). Myb TFs are mostly ubiquitously expressed ( Figure S4 ), 113 whereas homeobox, POU-homeobox ( Figure S5 ) and forkhead ( Figure S6 ) TFs display high time-and 114 organ-specificity ( Figure S2 ). Although only 16% of zinc finger TFs show spatiotemporal specificity, 115 they constitute ~1/4 of all time-and/or organ-specific TFs due to their high abundance. Another 116 ~1/4 corresponds to homeobox TFs, and the remaining half derive from various classes of TFs. 117 Notable among homeobox TFs are the Hox genes, which are critical for pattern specification at the 118 earliest stages of development [21] . In the developmental span examined in our study, Hox genes 119 play an important role during the development of the urogenital system and the early hindbrain 120 (but not cerebrum) ( Figure S7 ). Figure   125 embryonic lethality and are, congruently, the most pleiotropic. Genes that when mutated range 137 from lethality to causing disease (often developmental disorders affecting multiple organs) are less 138 pleiotropic than embryonic lethals but are more pleiotropic than genes only associated with disease 139 (both P-value = 2 x 10 -16 , Wilcoxon rank sum test, two-sided; Figure 2B ). Finally, non-lethal disease 140 genes are more pleiotropic than genes not associated with deleterious phenotypes (P-value = 2 x 141 10 -5 ; Figure 2B ). A similar association is obtained when looking independently at organ-and time-142 specificity ( Figure S8A ).
144
Human diseases differ in terms of severity, age of onset and organs affected, all of which should be 145 reflected in the spatiotemporal expression profiles of underlying disease genes. We therefore 146 looked at the time-and organ-specificity of genes associated with different classes of disease [23] 147 ( Figure 2C ). As expected, the specificity of the spatiotemporal profiles of disease genes differs 148 considerably among disease classes. Genes implicated in developmental disorders, cancer and 149 diseases of the nervous system tend to be ubiquitously expressed (spatially and temporally), 150 whereas genes causing heart and reproductive diseases tend to have more restricted expression 151 ( Figure 2C ). Further insights were obtained by analysing the temporal trajectories of disease genes 152 within the organs they affect. We used a soft clustering approach to identify the most common 153 expression profiles in each organ and assigned each gene a probability of belonging to each of the 154 clusters (Methods ; Table S2 ). Disease genes are enriched within specific clusters, which are disease 155 and organ-specific. For example, genes associated with heart disease are significantly enriched 156 among genes characterized by a progressive increase in expression throughout heart development, Within the brain, we focused on the temporal trajectories of genes associated with three 161 neurodevelopmental disorders: primary microcephaly, autism and schizophrenia (Methods). 162 Consistent with these disorders having different etiologies and ages of onset, the associated genes 163 are significantly enriched among distinct temporal profiles in the brain ( Figure 2D ). Genes causing 164 primary microcephaly show their highest expression at the earliest developmental stages followed 165 by a progressive decrease in expression, whereas genes implicated in schizophrenia show the 166 opposite profile: a progressive increase in expression throughout development ( Figure 2D ). Genes 167 associated with autism are expressed throughout prenatal development and subsequently display 168 a sharp decrease in expression near birth ( Figure 2D ). The two temporal profiles in the brain that 169 are enriched with microcephaly-and autism-associated genes are also enriched with essential genes 170 (P-value < 10 -16 , binomial test). 171 172 Most (86%) disease genes that we analyzed are associated with phenotypes in multiple organs, but 173 this still leaves hundreds of genes that affect exclusively one organ. Many of these genes present a 174 puzzle in biomedical research because, as previously noted [24, 25] , they are not expressed in an 175 organ-specific manner. Our analysis of developmental transcriptomes further strengthens this 176 puzzle. Genes known to cause organ-specific phenotypes exhibit dynamic temporal profiles in a 177 similar number of organs as genes causing phenotypes across multiple organs (i.e., median of 4 178 organs for both gene sets; Figure S9A ). This raises the question as to why mutations that mostly 179 disrupt the coding-sequences of genes temporally dynamic in multiple organs lead to diseases that 180 are organ-specific. A number of different factors may explain this phenomenon, including 181 alternative splicing (e.g., mutations may affect only organ-specific isoforms) [26] , functional 182 redundancy [25] , and/or dependency on the characteristics of specific cell types (e.g., protein-183 misfolding diseases in long-lived neurons). It has also been suggested that pathologies tend to be 184 associated with the organ where the genes display elevated expression [24] . This prompted us to 185 ask where genes associated with organ-specific diseases exhibit their maximum expression during 186 development. We focused on heart, neurodevelopmental, psychiatric, and metabolic diseases (the 187 latter tested in association with the liver). We found a strong association between the organ of 188 maximum expression during development and the organ where the pathology manifests ( Figure   189 2E). Thus, we found that 56% of the genes exclusively associated with heart disease show maximal 190 expression in the heart (vs. 15% for all genes, P-value = 2 x 10 -16 , binomial test; Figure 2E ), that 56% 191 of the genes with an exclusively metabolic phenotype show maximal expression in the liver (vs. 19% 192 for all genes, P-value = 2 x 10 -16 ; Figure 2E ), and that genes exclusively associated with 9 neurodevelopmental diseases are enriched for maximal expression in the brain (39% vs. 32% for all 194 genes, P-value = 0.03; Figure 2D ). The duration of gene expression may also help to explain organ-195 specific pathologies, at least for heart disease. Genes expressed in multiple organs that have heart-196 specific phenotypes are ubiquitously expressed during heart development but show a significantly 197 higher time-specificity (i.e., shorter expression window) in the other organs (all P-value < 10 -4 , 198 Wilcoxon rank sum test, two-sided; Figure 2F ). We note, however, that time-specificity does not 199 help to explain metabolic-or neurodevelopmental-specific phenotypes, as we see no difference in 200 the time-specificity of genes in the affected organs versus the others ( Figure 2F ; Figure S9B ). Overall, 201 the association of pathology with level of gene expression, and to a lesser extent with duration of 202 gene expression, suggest that the development of organ-specific pathologies can at least in some 203 cases be explained by differences in the abundance (spatial and/or temporal) of the cell type(s) that 204 express the mutated gene in the different organs. We first compared human genes and their orthologs in mouse, rat, rabbit and rhesus macaque in 228 terms of stark differences in spatiotemporal profiles: presence/absence of gene expression in a 229 given organ and large differences in expression pleiotropy across multiple organs. Differences 230 between humans and each of the other species in terms of the presence or absence of gene 231 expression in an organ are rare. In a comparison of human and mouse, only 1-3% of protein-coding 232 genes (177 -372 genes depending on the organ) are robustly expressed (RPKM ≥ 5) in human but 233 not in mouse (RPKM ≤ 1). These percentages are similar for the comparisons with the other species 234 (i.e., 1-2% of genes robustly expressed in human are not expressed in rat/rabbit/rhesus macaque). 235 Although rare, these differences also include disease genes. For example, among genes robustly 236 expressed in heart in human but not in mouse are 17 genes associated with heart disease. These 237 include NKX2-6, which causes conotruncal heart malformations in human [28] that, congruently, are 238 not recapitulated by a mouse knockout [29] . The developmental profile of NKX2-6 in the human 239 heart is ancestral; the heart expression was lost specifically in rodents, and this is therefore an 240 example of a disease gene that would probably be better studied in the rabbit ( Figure 3A ). Genes 241 associated with neurological diseases are depleted among the set of genes expressed in the human 242 but not in the mouse brain (12 differ vs. 28 expected, P-value = 4 x 10 -4 , binomial test). Among the 243 exceptions is CHRNA2, a gene expressed in the human brain starting at birth that has been 244 implicated in epilepsy [30, 31] . Once again, and congruently, this clinical phenotype is not 245 recapitulated in the mouse knockout [29] ( Figure 2B ). The global breadth of spatiotemporal expression is also very similar between human genes and their 248 orthologs in mouse, rat, rabbit and rhesus macaque. They are highly correlated in terms of their 249 organ-specificity (Pearson's r = 0.85-0.86, all P-value < 10 -16 ), time-specificity (r = 0.68-0.84 for 250 individual organs and 0.83-0.84 for median time-specificity, all P-value < 10 -16 ) and, therefore, for 251 global expression pleiotropy (r = 0.84-0.90, all P-value < 10 -16 ). There are only 141 genes expressed 252 in at least half the human samples but in fewer than 10% of the mouse samples, and 172 genes with 253 the opposite pattern ( Figure S9C ). These genes are depleted for essential genes (P-value = 8 x 10 -6 , 254 binomial test) and disease genes (P-value = 0.02, binomial test). Overall, differences in the breadth 255 and presence/absence of gene expression between humans and other species are confined to a 256 small set of genes. However, when present, they can translate into relevant phenotypic differences. Organ-specific temporal differences are common 266 It is not uncommon for genes with broad spatiotemporal profiles to evolve new organ 267 developmental trajectories in specific species or lineages [13] . Differences between mammalian 268 species in organ developmental trajectories were first identified using a phylogenetic approach that 269 included distantly related species (i.e., the marsupial opossum which diverged from human ~160 270 million years ago [32]) [13] . Therefore, only a restricted set of human genes was evaluated for 271 potential trajectory differences (e.g., 3,980 genes in the brain). Here, we compared the human 272 developmental profiles in each of the organs with their orthologs in mouse, rat, rabbit and rhesus 273 macaque in a pairwise manner (Methods; Tables S3-S8; because of the shorter rhesus macaque's 274 time series, this analysis was only performed for brain, heart and liver). This allowed us to duplicate 275 or triplicate (depending on the organ) the number of orthologous genes analyzed for differences in 276 their developmental trajectories. Figure Consistent with the original study [13] , we found differences between the organs in the proportion 280 of genes with trajectories differences between humans and each of the other species ( Figure 4B ): 281 differences are highest in testis and liver and lowest in brain. There are also expected differences 282 between species: a smaller fraction of genes differs between human and rhesus macaque (diverged 283 ~29 million years ago) than between human and each of the glires (diverged ~90 million years ago). 284 However, we also identified a higher proportion of genes that differ between human and mouse 285 than between human and rabbit (despite the same divergence time), a result consistent with the 286 original observation that rodents have evolved a larger number of trajectory differences [13].
288
Genes with different developmental trajectories between human and mouse are common: 51% of 289 the genes tested differ in at least one organ. Most of these genes (67%) differ in only one organ 290 (25% of genes differ in two organs, and 8% differ in 3 or more), despite on average showing dynamic 291 temporal profiles in 5-6 organs. Genes with differences in developmental trajectories are depleted 292 for TFs (P-value = 2 x 10 -5 , Fisher's exact test, two-sided) and are functionally enriched for protein 293 metabolism (Benjamini-Hochberg corrected P-value = 1 x 10 -4 , overrepresentation enrichment 294 analysis). Interestingly, genes with different trajectories in the brain (but not in the other organs) 295 are enriched among a set of genes identified as carrying signs of positive-selection in their coding-296 sequences across mammalian species [33] (P-value = 0.008, Fisher's exact test).
298
The genes depicted in Figure 4A are associated with diseases that affect the organ in which human 299 and mouse display different trajectories. For these genes, the disease etiology may not be fully 300 recapitulated by mouse models. The mouse knockouts are still expected to affect the development 301 of the organ associated with the disease, but the cellular and developmental context of the 302 phenotypes in mouse could differ substantially from those in human. It is therefore noteworthy that 303 genes associated with human disease are less likely than non-disease genes to differ in their 304 trajectories between human and mouse ( Figure 4C ; and between human and the other species; data 305 not shown). Genes causing diseases that affect the brain, heart and liver are significantly depleted 306 for trajectory differences between human and mouse in each of the organs ( Figure 4C , P-value = 307 not be fully recapitulated in the mouse ( Figure 4C ). 310 311 We also posed the question as to whether genes underlying diseases with different ages of onset 312 are equally likely to differ between human and mouse. Although the number of disease genes 313 associated with an exclusive congenital or exclusive postnatal onset is low, we found that genes 314 with congenital onsets almost never differ in terms of their developmental trajectories between 315 human and mouse (i.e., only 1 out of 82 genes causing disease in the brain, heart or liver; Figure 4C ) 316 whereas genes with postnatal onsets are more likely to show differences (although this difference 317 is only statistically significant for the liver, P-value = 0.03, binomial test; Figure 4C ). Overall, we 318 suggest that for genes with differences in developmental trajectories (Tables S3-S8 We integrated datasets of human essential and disease genes with developmental gene expression 332 profiles in order to shed new light on the causes and phenotypic manifestations of human diseases. 333 We found that the breadth of spatiotemporal expression correlates positively with the severity of 334 phenotypes and that it differs considerably among genes associated with different disease classes. 335 We also found that disease-associated genes are enriched within specific developmental modules 336 in the organs affected, and that genes associated with different brain developmental disorders show 337 distinct temporal profiles during brain development. There is therefore a clear association between 338 spatiotemporal profiles and the phenotypic manifestations of diseases.
340
The analysis of developmental transcriptomes further strengthened the apparent paradox of 341 ubiquitously expressed genes often having organ-specific phenotypes [24, 25] . We could not 342 distinguish genes associated with organ-specific phenotypes from those associated with multi-343 organ phenotypes based on the breadth of spatiotemporal profiles. However, for genes associated 344 with organ-specific phenotypes, there is a strong association between the organ affected and the 345 organ of maximal expression during development. This association suggests that at least some 346 organ-specific pathologies could be explained by differences between organs in the spatial and 347 temporal abundance of the cells expressing the mutated gene. 348 349 Gene expression links genes with their organismal phenotypes and hence offers a direct means to 350 compare both across species. It can, therefore, inform on the likelihood that insights obtained from 351 studies in model species are directly transferable to human. We found that stark changes in gene 352 expression (e.g., presence/absence of expression) are rare between species. However, they do 353 sometimes occur in disease genes, and in these cases, they may explain why for these genes mouse 354 models fail to recapitulate the human phenotypes. Strikingly, we also found that differences 355 between humans and other species in terms of the genes' temporal trajectories during organ 356 development are common. About half of human genes exhibit a different developmental trajectory 357 from their mouse orthologs in at least one of the organs. In further support of the use of model 358 organisms for disease research, we found that disease genes are less likely to differ than the average 359 gene. Nevertheless, we still identified more than 200 genes known to be causally associated with 360 brain, heart and/or liver disease, that differ in developmental trajectories between human and 361 mouse in the affected organ. 362 363 Different reasons, that are not mutually exclusive, can account for the differences in temporal 364 trajectories observed between species. Differences in developmental trajectories can be created by 365 gene expression differences between species in homologous cell types, differences between species 366 in cellular composition, and/or differences between species in the cell types that express 367 orthologous genes. All of these differences can decrease the likelihood that the phenotype 368 associated with a human gene will be fully recapitulated in a model species. However, differences 369 in trajectories created by changes in the identity of the cell types that express an orthologous gene 370 in different species will lead to the greatest phenotypic divergence. Endeavors that seek to clarify 371 the causes of trajectory differences therefore represent a key next step, given that they will identify 372 further genes and processes that are challenging to model in other species. The use of single-cell 373 technologies will greatly aid these efforts [34] . Gene co-expression networks 416 We built gene co-expression networks using weighted correlation network analysis (WGCNA 1.61) 417 [35] . We used as input data the read counts after applying the variance stabilizing (VS) 418 transformation implemented in DESeq2 (1.12.4) [36] . Each stage was represented by the median 419 across replicates. In addition to protein-coding genes, we included a set of 5,887 lncRNAs that show 420 significant differential temporal expression in at least one organ and that show multiple signatures 421 for being enriched with functional genes [19] . We only excluded genes that failed to reach an RPKM 422 (reads per kilobase of exon model per million mapped reads) across all stages and organs higher 423 than 1. Using WGCNA we built a signed network (based on the correlation across all stages and 424 organs) using a power of 10 and default parameters. We then correlated the eigengenes for each 425 module with the sample traits (i.e., organ and developmental stage). Inherited disease genes 438 The list of genes associated with human inherited disease was obtained from the manually curated 439 HGMD (PRO 17.1) [23] . We only used genes with disease-causing mutations (DM tag; Table S2 ). 440 Genes associated with DM mutations were mapped onto the Unified Medical Language System 441 (UMLS), and aggregated into one or more of the following high level disease types: Eye, Nervous The most common temporal profiles in each organ were identified using the soft-clustering 458 approach (c-means) implemented in the R package mFuzz (2.32.0) [42, 43] . The clustering was 459 restricted to genes previously identified as showing significant temporal differential expression in 460 each organ (i.e., developmentally dynamic genes) [13] . We used as input the VS-transformed 461 counts. The number of clusters was set to 6-8 depending on the organ.
462
Comparing developmental trajectories 463 For each organ, we compared the developmental trajectories of orthologous genes previously 464 identified as showing significant temporal differential expression [13] . We used as input the VS-465 transformed counts (median across replicates) for matching stages between human and each of the 466 other species. The developmental stage correspondences across species were retrieved from the 467 developmental resource [13] . We used GPClust [44] [45] [46] , which clusters time-series using Gaussian 468 processes, to cluster the combined data for human and each of the other species. We set the noise 469 variance (k2.variance.fix) to 0.7 and let GPClust infer the number of clusters. For each gene, GPClust 470 assigned the probability of it belonging to each of the clusters. Therefore, for each gene we obtained 471 a vector of probabilities that could be directly compared between pairs of 1:1 orthologs. We 472 calculated the probability that pairs of orthologs were in the same cluster and used an FDR cut off 473 of 5% to identify the genes that differed in trajectory between human and each of the other species. 474 In Tables S3-S8, we provide for each organ and species the P-values (adjusted for multiple testing 475 using the Benjamini-Hochberg procedure [47]) for the null hypothesis that orthologs have the same 476 trajectory, and their classification as 'same' or 'different' based on an FDR of 5%. Pisano, T., Pruna, D., et al. (2006) Table S2 . Lists of human genes, the modules to which they belong in the global gene co-expression 677 network, the clusters to which they were assigned in each organ ( (450) M16 (701) M17 (509) M18 (225) M19 (130) M20 (822) M21 (693) M22 (1134) M23 (432) M24 (155) M25 (531) M26 (197) M27 (142) M28 ( 
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• CALR3  BOLL  PIH1D3  RNF113B  ADAD1  RBMXL3  DDX53  PIWIL3  NANOS2  ZCCHC13  APOBEC4  NCBP2L  PIWIL1  RBMXL2  RBM46  RNF17  DAZL  TDRD1  ADAD2  RPL10L  TDRD15  TLR8  RNASE3  TERT  IFIT1B  RNASE9  RNASE7  ZCCHC5  RNASE13  EIF4E1B  NXF5  PABPN1L  MOV10L1  RBM44  PAPOLB  ENDOU  RP11−111H13.1   TDRD12  TDRD5  CPEB1  NR0B1  PATL2  ISG20  OASL  NXF3  APOBEC3H  RNASE2  DQX1  LIN28A  LIN28B   RPS17  ANKHD1  EIF2S3L  DDX47  POLR2J3  ARL6IP4  ADAT3  PPAN  SARNP  AARSD1  PTCD1  PSMA6  RNASEK  EIF3C  SMN2  EIF5AL1  HELZ2  ARHGEF28  PPARGC1B  ZC3H12B  NANOS1  TLR3  OAS2  OAS1  ZC3H12A  DDX43  TDRD9  PIWIL2  MAEL  YBX2  ESRP1  RBM20  RPL3L  APOBEC2  A1CF  AZGP1  ADARB2  MKRN3  SIDT1  TDRD6  NPM2  SRRM4  ELAVL4  CELF4  CELF5  ELAVL3  CELF3 −10 −5 0 5 10 log2(RPKM) Figure S3 . Spatiotemporal profiles of time and/or organ-specific RBPs (organ-and/or median time-specificity ≥ 0.8). In each organ, the samples are ordered from early to late development. Figure S8 . Spatiotemporal profiles of disease genes. (A) Organ-and time-specificity (median across organs) for genes in different classes of phenotypic severity (P-values from Wilcoxon rank sum test, two-sided). The box plots depict the median ± 25th and 75th percentiles, whiskers at 1.5 times the interquartile range. (B) Distribution of genes associated with heart disease among the 6 heart clusters. Cluster 1 is enriched for heart disease-associated genes both when using all genes associated with a heart phenotype (n = 230) and when restricting the set to those exclusively associated with the heart (n = 46) (P-values from binomial tests). (C) Distribution of genes associated with metabolic diseases among the 6 liver clusters. Cluster 5 is enriched for metabolic disease-associated genes both when using all genes associated with a metabolic phenotype (n = 379) and when restricting the set to those exclusively associated with metabolism (n = 103) (P-values from binomial tests). Relationship between human and mouse expression pleiotropy. The blue dots denote diseaseassociated genes and the orange dots denote disease-associated genes expressed in at least 50% of the samples in one species but in less than 10% of the samples in the other. In (A) and (B) the box plots depict the median ± 25th and 75th percentiles, whiskers at 1.5 times the interquartile range. Disease gene pleiotropic in one species and specific in the other
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